Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis

Ping Yuan(Anhui Medical University), Bin Zheng(Harvard University), Jason Roszik(The University of Texas MD Anderson Cancer Center), Sebastian Trousil(Harvard University), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Y.N. Vashisht Gopal(The University of Texas MD Anderson Cancer Center), Man Li(Harvard University), Evelyn de Groot(The University of Texas MD Anderson Cancer Center), Da Teng(Changchun University of Science and Technology), Che‐Hung Shen(Kaohsiung Medical University)
iScience
April 29, 2023
10.1016/j.isci.2023.106791
Cited by 11

Related Papers

Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
|Cell|2008|2.6k
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
|New England Journal of Medicine|2019|1.4k
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2012|906
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
|Science|2021|876
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
|Annals of Oncology|2016|822